Biondo Investment Advisors’s Sanofi Contingent Value Rights GCVRZ Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2020
Q1 | – | Sell |
-10,800
| Closed | -$9K | – | 91 |
|
|
2019
Q4 | $9K | Hold |
10,800
| – | – | ﹤0.01% | 87 |
|
|
2019
Q3 | $6K | Hold |
10,800
| – | – | ﹤0.01% | 86 |
|
|
2019
Q2 | $6K | Sell |
10,800
-1,825
| -14% | -$911 | ﹤0.01% | 88 |
|
|
2019
Q1 | $6K | Buy |
12,625
+150
| +1% | +$70 | ﹤0.01% | 81 |
|
|
2018
Q4 | $6K | Sell |
12,475
-1,200
| -9% | -$596 | ﹤0.01% | 79 |
|
|
2018
Q3 | $7K | Sell |
13,675
-250
| -2% | -$134 | ﹤0.01% | 80 |
|
|
2018
Q2 | $7K | Hold |
13,925
| – | – | ﹤0.01% | 81 |
|
|
2018
Q1 | $6K | Sell |
13,925
-200
| -1% | -$80 | ﹤0.01% | 88 |
|
|
2017
Q4 | $5K | Hold |
14,125
| – | – | ﹤0.01% | 96 |
|
|
2017
Q3 | $5K | Hold |
14,125
| – | – | ﹤0.01% | 93 |
|
|
2017
Q2 | $5K | Sell |
14,125
-1,525
| -10% | -$623 | ﹤0.01% | 79 |
|
|
2017
Q1 | $4K | Buy |
15,650
+725
| +5% | +$318 | ﹤0.01% | 76 |
|
|
2016
Q4 | $6K | Hold |
14,925
| – | – | ﹤0.01% | 75 |
|
|
2016
Q3 | $4K | Sell |
14,925
-825
| -5% | -$209 | ﹤0.01% | 77 |
|
|
2016
Q2 | $4K | Sell |
15,750
-400
| -2% | -$69 | ﹤0.01% | 76 |
|
|
2016
Q1 | $2K | Sell |
16,150
-325
| -2% | -$35 | ﹤0.01% | 73 |
|
|
2015
Q4 | $2K | Sell |
16,475
-275
| -2% | -$39 | ﹤0.01% | 79 |
|
|
2015
Q3 | $3K | Sell |
16,750
-150
| -0.9% | -$51 | ﹤0.01% | 81 |
|
|
2015
Q2 | $12K | Sell |
16,900
-100
| -0.6% | -$69 | ﹤0.01% | 83 |
|
|
2015
Q1 | $12K | Hold |
17,000
| – | – | ﹤0.01% | 80 |
|
|
2014
Q4 | $13K | Sell |
17,000
-125
| -0.7% | -$85 | ﹤0.01% | 83 |
|
|
2014
Q3 | $8K | Sell |
17,125
-175
| -1% | -$85 | ﹤0.01% | 84 |
|
|
2014
Q2 | $9K | Hold |
17,300
| – | – | ﹤0.01% | 89 |
|
|
2014
Q1 | $5K | Hold |
17,300
| – | – | ﹤0.01% | 92 |
|
|
2013
Q4 | $6K | Sell |
17,300
-300
| -2% | -$363 | ﹤0.01% | 97 |
|
|
2013
Q3 | $36K | Sell |
17,600
-425
| -2% | -$809 | 0.01% | 94 |
|
|
2013
Q2 | $34K | Buy |
+18,025
| New | +$31.7K | 0.01% | 87 |
|
Biondo Investment Advisors's GCVRZ Position: Q1 2020 in Review
Biondo Investment Advisors sold out of Sanofi Contingent Value Rights (GCVRZ) in Q1 2020, closing a stake of 10,800 shares — an estimated $9K sold.
Biondo Investment Advisors first reported a position in GCVRZ in Q2 2013 and held it in 27 quarters. The position peaked at $36K in Q3 2013. 2 funds tracked by Wall St. Rank hold GCVRZ as of Q1 2020.
- Biondo Investment Advisors reported no remaining Sanofi Contingent Value Rights position as of Q1 2020 after selling out during the quarter.
- Biondo Investment Advisors sold 10,800 Sanofi Contingent Value Rights shares in Q1 2020, an estimated $9K.
- Biondo Investment Advisors first reported a position in Sanofi Contingent Value Rights in Q2 2013 and held it in 27 quarters.
- Biondo Investment Advisors's Sanofi Contingent Value Rights position peaked at $36K in Q3 2013.
- 2 funds tracked by Wall St. Rank held Sanofi Contingent Value Rights as of Q1 2020.
Based on Biondo Investment Advisors's 13F filing for Q1 2020, filed 8 May 2020.